Contra my earlier post, several categories did show statistically significant improvement, including muscle weakness and shortness of breath, despite the small trial size of 54 patients, according to a CC summary on Yahoo by Bill El Gordo:
<The Long haulers trial was designed to be exploratory. P value on joint pain and swelling over 56 days was <.0001, which is excellent. That was for a 360% improvement in symptoms. Same p value for tightness in chest; 171% symptom improvement. Same p value for tingling or numbness; 156% improvement. Muscle weakness .013 p value, sleep disturbance .01, headache .0001. .032 shortness of breath, nausea .028, repeated that FDA said this trial is exploratory.>